InvestorsHub Logo
Followers 89
Posts 17441
Boards Moderated 0
Alias Born 09/06/2006

Re: abeta post# 665142

Thursday, 01/18/2024 12:07:25 PM

Thursday, January 18, 2024 12:07:25 PM

Post# of 702655
Plenty of published results on their trials can be found here

It is definitely not DCvax-L despite being lysate based. And one of the 2 flavors does not even extract monocytes to grow DCs, it injects the lysate into the patient so it is recognized by DCs and other APC in vivo.

Two trial can be found on ct.gov. One of each type.

There core differentiator from the other numerous ATL-DCs is that they embed the lysate into a particle made of yeast cell wall material. Supposedly makes it tastier to the DCs.

They do extract the lysate via a freeze-thaw cycle, which I think was NWBO's core differentiator from the late 1990s.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News